A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.

Neurology 2004 Oct;63(7):1155-62

Center for Aging and Developmental Biology, University of Rochester School of Medicine, Rochester, NY 14642-8673, USA.

Synaptic dysfunction and failure are processes that occur early in Alzheimer disease (AD) and are important targets for protective treatments to slow AD progression and preserve cognitive and functional abilities. Synaptic loss is the best current pathologic correlate of cognitive decline, and synaptic dysfunction is evident long before synapses and neurons are lost. Once synaptic function fails, even in the setting of surviving neurons, there may be little chance of effectively interfering with the disease process. This review emphasizes the importance of preserving synaptic structure and function (i.e., "synaptoprotection") in AD. Such "synaptoprotective" therapy will probably need to be administered at a critical early time point, perhaps years before onset of clinical symptoms.

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000140626.48118.0aDOI Listing
October 2004

Publication Analysis

Top Keywords

synaptic dysfunction
8
alzheimer disease
8
synaptic
5
lost synaptic
4
function fails
4
synaptic function
4
setting surviving
4
effectively interfering
4
chance effectively
4
neurons chance
4
surviving neurons
4
fails setting
4
synapses neurons
4
correlate cognitive
4
pathologic correlate
4
current pathologic
4
best current
4
cognitive decline
4
decline synaptic
4
interfering disease
4

Altmetric Statistics

Similar Publications